Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review)
- PMID: 34603766
- PMCID: PMC8482826
- DOI: 10.17691/stm2021.13.4.08
Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review)
Abstract
Proton therapy (PT) due to dosimetric characteristics (Bragg peak formation, sharp dose slowdown) is currently one of the most high-tech techniques of radiation therapy exceeding the standards of photon methods. In recent decades, PT has traditionally been used, primarily, for head and neck cancers (HNC) including skull base tumors. Regardless of the fact that recently PT application area has significantly expanded, HNC still remain a leading indication for proton radiation since PT's physic-dosimetric and radiobiological advantages enable to achieve the best treatment results in these tumors. The present review is devoted to PT usage in HNC treatment in the world and Russian medicine, the prospects for further technique development, the assessment of PT's radiobiological features, a physical and dosimetric comparison of protons photons distribution. The paper shows PT's capabilities in the treatment of skull base tumors, HNC (nasal cavity, paranasal sinuses, nasopharynx, oropharynx, and laryngopharynx, etc.), eye tumors, sialomas. The authors analyze the studies on repeated radiation and provide recent experimental data on favorable profile of proton radiation compared to the conventional radiation therapy. The review enables to conclude that currently PT is a dynamic radiation technique opening up new opportunities for improving therapy of oncology patients, especially those with HNC.
Keywords: head and neck cancer; proton therapy; reirradiation therapy.
Conflict of interest statement
Conflicts of interest. The authors declare no conflicts of interest related to the present study.
Similar articles
-
Proton Therapy for Head and Neck Cancers.Semin Radiat Oncol. 2018 Jan;28(1):53-63. doi: 10.1016/j.semradonc.2017.08.004. Semin Radiat Oncol. 2018. PMID: 29173756 Review.
-
Radiation dose-painting with protons vs. photons for head-and-neck cancer.Acta Oncol. 2020 May;59(5):525-533. doi: 10.1080/0284186X.2020.1714720. Epub 2020 Jan 21. Acta Oncol. 2020. PMID: 31964199
-
Proton therapy for skull-base adenoid cystic carcinomas: A case series and review of literature.J Cancer Res Ther. 2022 Apr-Jun;18(3):629-637. doi: 10.4103/jcrt.jcrt_1236_21. J Cancer Res Ther. 2022. PMID: 35900533 Review.
-
Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.Oral Oncol. 2019 Jan;88:66-74. doi: 10.1016/j.oraloncology.2018.11.015. Epub 2018 Nov 21. Oral Oncol. 2019. PMID: 30616799 Free PMC article. Review.
-
Protons vs Photons for Brain and Skull Base Tumors.Semin Radiat Oncol. 2018 Apr;28(2):97-107. doi: 10.1016/j.semradonc.2017.11.001. Semin Radiat Oncol. 2018. PMID: 29735196 Review.
Cited by
-
Upright proton therapy for esthesioneuroblastoma: a single-institution experience.Front Oncol. 2024 Jan 30;14:1348291. doi: 10.3389/fonc.2024.1348291. eCollection 2024. Front Oncol. 2024. PMID: 38352894 Free PMC article.
-
CYRAD: a translational study assessing immune response to radiotherapy by photons or protons in postoperative head and neck cancer patients through circulating leukocyte subpopulations and cytokine levels.BMC Cancer. 2024 Oct 5;24(1):1230. doi: 10.1186/s12885-024-13002-1. BMC Cancer. 2024. PMID: 39369231 Free PMC article.
-
Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base: Evaluation of the Effectiveness of Treatment Methods (Review).Sovrem Tekhnologii Med. 2023;15(5):44-52. doi: 10.17691/stm2023.15.5.05. Epub 2023 Oct 30. Sovrem Tekhnologii Med. 2023. PMID: 39967912 Free PMC article. Review.
-
A Longitudinal Metagenomic Comparative Analysis of Oral Microbiome Shifts in Patients Receiving Proton Radiation versus Photon Radiation for Head and Neck Cancer.J Cancer Allied Spec. 2024 Jan 22;10(1):579. doi: 10.37029/jcas.v10i1.579. eCollection 2024. J Cancer Allied Spec. 2024. PMID: 38259673 Free PMC article.
-
Is noncoplanar plan more robust to inter-fractional variations than coplanar plan in treating bilateral HN tumors with pencil-beam scanning proton beams?J Appl Clin Med Phys. 2024 Feb;25(2):e14186. doi: 10.1002/acm2.14186. Epub 2023 Nov 16. J Appl Clin Med Phys. 2024. PMID: 37974385 Free PMC article.
References
-
- Kaprin A.D., Starinskiy V.V., Petrova G.V., editors. Sostoyanie onkologicheskoy pomoshchi naseleniyu rossii v 2018 godu. Moscow: MNIOI im. P.A. Gertsena — filial FGBU “NMIRTs” Minzdrava Rossii; 2019. p. 236. [The state of oncological care for the population of Russia in 2018].
-
- Nutting C.M., Morden J.P., Harrington K.J., Urbano T.G., Bhide S.A., Clark C., Miles E.A., Miah A.B., Newbold K., Tanay M., Adab F., Jefferies S.J., Scrase C., Yap B.K., A’Hern R.P., Sydenham M.A., Emson M., Hall E. PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomized controlled trial. Lancet Oncol. 2011;12(2):127–136. doi: 10.1016/s1470-2045(10)70290-4. - DOI - PMC - PubMed
-
- Peng G., Wang T., Yang K.Y., Zhang S., Zhang T., Li Q., Han J., Wu G. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012;104(3):286–293. doi: 10.1016/j.radonc.2012.08.013. - DOI - PubMed
-
- Rosenthal D.I., Chambers M.S., Fuller C.D., Rebueno N.C., Garcia J., Kies M.S., Morrison W.H., Ang K.K., Garden A.S. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;72(3):747–755. doi: 10.1016/j.ijrobp.2008.01.012. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical